State Street Corp Royalty Pharma PLC Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, State Street Corp holds 9,516,128 shares of RPRX stock, worth $346 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,516,128

Previous 9,760,163 2.5%

Holding current value

$346 Million

Previous $249 Million 18.98%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $6.28 Million - $8.26 Million	-244,035 Reduced 2.5%	9,516,128 $296 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $5.92 Million - $6.92 Million	243,901 Added 2.56%	9,760,163 $249 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $754,829 - $862,030	29,451 Added 0.31%	9,516,262 $269 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $10.2 Million - $11.6 Million	386,663 Added 4.25%	9,486,811 $250 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $6.22 Million - $7.1 Million	226,598 Added 2.55%	9,100,148 $276 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $11.7 Million - $13.1 Million	447,934 Added 5.32%	8,873,550 $249 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $6.27 Million - $7.49 Million	238,778 Added 2.92%	8,425,616 $229 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $4.56 Million - $5.63 Million	-153,967 Reduced 1.85%	8,186,838 $252 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $7.24 Million - $8.7 Million	220,923 Added 2.72%	8,340,805 $301 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $7.77 Million - $8.74 Million	198,467 Added 2.51%	8,119,882 $321 Million
Q3 2022 Nov 15, 2022	BUY	$39.88 - $44.65 $11 Million - $12.4 Million	276,675 Added 3.62%	7,921,415 $318 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $4.42 Million - $5.21 Million	-117,832 Reduced 1.52%	7,644,740 $321 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $25.7 Million - $29.1 Million	685,242 Added 9.68%	7,762,572 $302 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $43.7 Million - $52.8 Million	1,242,585 Added 21.3%	7,077,330 $282 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $35 Million - $40.9 Million	967,111 Added 19.87%	5,834,745 $211 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $7.24 Million - $8.48 Million	181,771 Added 3.88%	4,867,634 $200 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $98.6 Million - $123 Million	2,328,121 Added 98.74%	4,685,863 $204 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $48.4 Million - $67 Million	1,339,548 Added 131.56%	2,357,742 $118 Million
Q3 2020 Nov 10, 2020	BUY	$38.56 - $48.36 $37.7 Million - $47.3 Million	977,394 Added 2395.57%	1,018,194 $42.8 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $1.82 Million - $2.13 Million	40,800 New	40,800 $1.98 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Royalty Pharma PLC Transaction History